Table 1 Baseline characteristics of elderly patients with COVID-19
Total | Survivor | Non-survivor | P* | |
|---|---|---|---|---|
n = 147 (%) | n = 105 (%) | n = 42 (%) | ||
Age, yr (median, IQR) | 76 (72–81) | 75 (72–79) | 79 (75–84) | 0.005 |
Sex | 0.714 | |||
Male | 85 (57.8) | 62 (59.1) | 23 (54.8) | |
Female | 62 (42.2) | 43 (40.9) | 19 (45.2) | |
Symptoms | ||||
Fever | 119 (81.0) | 86 (81.9) | 33 (78.6) | 0.647 |
Cough | 88 (59.9) | 62 (59.1) | 26 (61.9) | 0.853 |
Dyspnea | 60 (40.8) | 38 (36.2) | 22 (52.4) | 0.094 |
Expectoration | 47 (32.0) | 31 (29.5) | 16 (38.1) | 0.333 |
Pharyngalgia | 7 (4.8) | 4 (3.8) | 3 (7.1) | 0.408 |
Nausea | 6 (4.1) | 4 (3.8) | 2 (4.8) | 0.999 |
Vomiting | 6 (4.1) | 3 (2.9) | 3 (7.1) | 0.354 |
Diarrhea | 15 (10.2) | 11 (10.5) | 4 (9.5) | 0.999 |
Fatigue | 62 (42.2) | 43 (41.0) | 19 (45.2) | 0.713 |
Myalgia | 5 (3.4) | 4 (3.8) | 1 (2.4) | 0.999 |
Comorbidity | ||||
Respiratory diseases | 27 (18.4) | 16 (15.2) | 11 (26.2) | 0.157 |
Cardiovascular disease | 79 (53.7) | 55 (52.4) | 24 (57.1) | 0.715 |
Endocrine System | 32 (21.8) | 25 (23.8) | 7 (16.7) | 0.385 |
Surgery | 32 (21.8) | 26 (17.7) | 6 (4.1) | 0.191 |
Tumor | 5 (3.4) | 4 (3.8) | 1 (2.4) | 0.999 |
Other comorbidities | 28 (19.1) | 18 (17.1) | 10 (23.8) | 0.360 |
Type | 0.001 | |||
General | 89 (60.5) | 73 (69.5) | 16 (38.1) | |
Severe | 42 (28.6) | 24 (22.9) | 18 (42.9) | |
Critical | 16 (10.9) | 8 (7.6) | 8 (19.0) | |